2nd Generation Smallpox Vaccine

Status Awarded

Contract number 6D024-203934/001/PH

Solicitation number 6D024-203934/A

Publication date

Contract award date

Contract value

USD 15,121,000.00
Description

This contract was awarded to:

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 
Trade Agreement: Canadian Free Trade Agreement (CFTA)
Comprehensive Land Claim Agreement: No
Notification Method: Public Advertising
Contract Award Procedure (Procurement Strategy): Exclusive Rights
GSIN Description: 
Drugs and Biologicals
Quantity: 1
Business address
Suite 100-300 Professional Drive
Gaithersburg, Maryland, 20879
United States
Procurement method
Non-Competitive
Language(s)
English
,
French

View the full contract history for EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC..

Contract duration

Refer to the description above for full details.

Commodity - GSIN

  • N6505 - Drugs and Biologicals

Reason for limited tendering

A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:

  • Exclusive Rights
Contact information

Contracting organization

Organization
Public Works and Government Services Canada
Address
11 Laurier St, Phase III, Place du Portage
Gatineau, Quebec, K1A 0S5
Canada
Contracting authority
PUBLIC HEALTH AGENCY OF CANADA
Address
PL6201A
100 COLONNADE RD
OTTAWA, ON, K1A0K9
CAN

Buying organization(s)

Organization
Public Health Agency of Canada
Address
130 Colonnade Road
Ottawa, Ontario, K1A 0K9
Canada
Date modified: